| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCNB1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | TAS2R10 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | TREH | CTRPv2 | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | LINC01207 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | RP11-613M10.9 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | ERCC1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | PDIK1L | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | MXI1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | ZMYM1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | ADH5 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
